Clinical Trials : Kidney Diseases, Cystic

Completed

Nombre del estudio: A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2016-07-21

Recruiting

Nombre del estudio: Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
Condición: ADPKD
Fecha: 2016-05-04
Intervenciones: Other: water

Not yet recruiting

Nombre del estudio: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2016-04-08
Intervenciones: Device: Vessix Renal denervation using radio-ablation

Completed

Nombre del estudio: Efficacy of Tolvaptan on ADPKD Patients
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2016-03-11
Intervenciones: Drug: Tolvaptan

Completed

Nombre del estudio: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Condición: Polycystic Kidney Disease
Fecha: 2015-10-30
Intervenciones:

Drug: Pioglitazone Pioglitazon

Completed

Nombre del estudio: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Condición: Polycystic Kidney, Autosomal Dominant
Fecha: 2015-12-23
Intervenciones:

Drug: Metformin Monitoring of

Active, not recruiting

Nombre del estudio: Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101
Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Fecha: 2015-11-24
Intervenciones: Drug: tesevatinib Other Name: KD019, XL647

Completed

Nombre del estudio: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condición: Polycystic Kidney Disease
Fecha: 2015-09-21
Intervenciones:

Dietary Supplement: Niacinamide

Completed

Nombre del estudio: Effect of the Aquaretic Tolvaptan on Nitric Oxide System
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2015-02-18
Intervenciones:

Drug: Tolvaptan 60 mg Tolvapta

Completed

Nombre del estudio: The German ADPKD Tolvaptan Treatment Registry
Condición: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Fecha: 2015-06-19

Buscar resultados de ensayos clínicos

Kidney Diseases, Cystic - 23 Studies Found

Estado	Estudiar
Completed	Nombre del estudio: A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2016-07-21
Recruiting	Nombre del estudio: Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease Condición: ADPKD Fecha: 2016-05-04 Intervenciones: Other: water
Not yet recruiting	Nombre del estudio: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2016-04-08 Intervenciones: Device: Vessix Renal denervation using radio-ablation
Completed	Nombre del estudio: Efficacy of Tolvaptan on ADPKD Patients Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2016-03-11 Intervenciones: Drug: Tolvaptan
Completed	Nombre del estudio: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condición: Polycystic Kidney Disease Fecha: 2015-10-30 Intervenciones: Drug: Pioglitazone Pioglitazon
Completed	Nombre del estudio: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Condición: Polycystic Kidney, Autosomal Dominant Fecha: 2015-12-23 Intervenciones: Drug: Metformin Monitoring of
Active, not recruiting	Nombre del estudio: Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101 Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Fecha: 2015-11-24 Intervenciones: Drug: tesevatinib Other Name: KD019, XL647
Completed	Nombre del estudio: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) Condición: Polycystic Kidney Disease Fecha: 2015-09-21 Intervenciones: Dietary Supplement: Niacinamide
Completed	Nombre del estudio: Effect of the Aquaretic Tolvaptan on Nitric Oxide System Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2015-02-18 Intervenciones: Drug: Tolvaptan 60 mg Tolvapta
Completed	Nombre del estudio: The German ADPKD Tolvaptan Treatment Registry Condición: ADPKD (Autosomal Dominant Polycystic Kidney Disease) Fecha: 2015-06-19